Pancreatic Juice Diagnosis From Duodenum
Completed · Not applicable
Conditions studied: Pancreatic Adenocarcinoma
In brief
Purpose of this study is to understand the clinical feasibility of duodenal juice diagnosis to screen UICC stage II pancreatic ductal adenocarcinoma patients.
Key facts
- Study ID
- NCT01699698
- Run by
- Olympus Corporation
- People needed
- 105
- Starts
- 2012-10-01
- Last updated by the study team
- 2015-09-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Common inclusion criterion
- Age is 18 years or older.
- Informed consent was obtained.
- Inclusion criterion for normal cohort
- An upper GI endoscopy is scheduled to check upper abdominal symptoms.
- No findings of pancreatic disorder as documented by CT or MRI or EUS
- Inclusion criterion for PC suspicious cohort
- A EUS or ERCP is scheduled to suspected pancreatic disorder.
You may not qualify if…
- Common exclusion criterion
- Severe cardiac disease
- Severe respiratory disease
- Bleeding disorders
- Pregnancy
Where it is running
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Kyushu University — Fukuoka, Fukuoka, Japan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.